Importantly, by generating NSMCE2 knockdown breast cancer cell lines, we showed that NSMCE2 plays a key role in resistance to doxorubicin treatment, probably due to its DNA repairing function, which reduces doxorubicin’s DNA damaging effect and prevents the activation of the apoptotic program. The gene discussed is NSMCE2; the disease is breast carcinoma.